Evidence map›Paper›PMID 37661929›Full record

ArticleProtein science : a publication of the Protein Society2023

Elucidation of binding mechanism, affinity, and complex structure between mWT1 tumor-associated antigen peptide and HLA-A*24:02.

Gert-Jan Bekker, Nobutaka Numoto, Maki Kawasaki, Takahiro Hayashi, Saaya Yabuno, Yuko Kozono, Takeyuki Shimizu, Haruo Kozono, Nobutoshi Ito, Masayuki Oda and 1 more

Open access · greenAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Gert-Jan BekkerInstitute for Protein Research, Osaka University, Suita, Osaka, Japan.ORCID 0000-0001-8385-5693
Nobutaka NumotoMedical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.ORCID 0000-0001-6113-9792
Maki KawasakiGraduate School of Life and Environmental Sciences, Kyoto Prefectural University, Kyoto, Kyoto, Japan.
Takahiro HayashiGraduate School of Life and Environmental Sciences, Kyoto Prefectural University, Kyoto, Kyoto, Japan.
Saaya YabunoGraduate School of Life and Environmental Sciences, Kyoto Prefectural University, Kyoto, Kyoto, Japan.
Yuko KozonoResearch Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan.
Takeyuki ShimizuDepartment of Immunology, Kochi Medical School, Kochi University, Nankoku-shi, Kochi, Japan.ORCID 0000-0002-3504-7875
Haruo KozonoResearch Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan.ORCID 0000-0003-3352-0638
Nobutoshi ItoMedical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Masayuki OdaGraduate School of Life and Environmental Sciences, Kyoto Prefectural University, Kyoto, Kyoto, Japan.ORCID 0000-0002-8568-4223
Narutoshi KamiyaGraduate School of Information Science, University of Hyogo, Kobe, Hyogo, Japan.ORCID 0000-0002-0527-6968
Kyoto Prefectural University · JPTokyo Medical and Dental University · JPTokyo University of Science · JPKochi Medical School Hospital · JPProtein Research Foundation · JPUniversity of Hyogo · JP

Funding

Japan Agency for Medical Research and Development JP20fk0108471Japan Agency for Medical Research and Development JP22zf0127004Japan Society for the Promotion of Science JP20H03229
6 · The paper itself

Abstract

We have applied our advanced computational and experimental methodologies to investigate the complex structure and binding mechanism of a modified Wilms' Tumor 1 (mWT1) protein epitope to the understudied Asian-dominant allele HLA-A*24:02 (HLA-A24) in aqueous solution. We have applied our developed multicanonical molecular dynamics (McMD)-based dynamic docking method to analyze the binding pathway and mechanism, which we verified by comparing the highest probability structures from simulation with our experimentally solved x-ray crystal structure. Subsequent path sampling MD simulations elucidated the atomic details of the binding process and indicated that first an encounter complex is formed between the N-terminal's positive charge of the 9-residue mWT1 fragment peptide and a cluster of negative residues on the surface of HLA-A24, with the major histocompatibility complex (MHC) molecule preferring a predominantly closed conformation. The peptide first binds to this closed MHC conformation, forming an encounter complex, after which the binding site opens due to increased entropy of the binding site, allowing the peptide to bind to form the native complex structure. Further sequence and structure analyses also suggest that although the peptide loading complex would help with stabilizing the MHC molecule, the binding depends in a large part on the intrinsic affinity between the MHC molecule and the antigen peptide. Finally, our computational tools and analyses can be of great benefit to study the binding mechanism of different MHC types to their antigens, where it could also be useful in the development of higher affinity variant peptides and for personalized medicine.

Indexed as

HLA-A24 AntigenMolecular Dynamics SimulationWT1 ProteinsBinding SitesHumansMolecular Docking SimulationPeptidesProtein BindingProtein ConformationHLA-A*24:02 antigenHLA-A24 AntigenPeptidesWT1 protein, humanWT1 Proteinsantigen peptidehuman leukocyte antigenisothermal titration calorimetrymulticanonical molecular dynamics simulationpath sampling simulationx-ray crystallography

Identifiers

PMID37661929
PMCPMC10510467
OpenAlexW4386407164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.